# Intravesical Electromotive Mitomycin After Bacillus Calmette-Guérin Failure

> **NCT04311580** · PHASE2 · COMPLETED · sponsor: **University of Rome Tor Vergata** · enrollment: 52 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **COMBINATION_PRODUCT:** intravesical electromotive administration of mitomycin

## Key facts

- **NCT ID:** NCT04311580
- **Lead sponsor:** University of Rome Tor Vergata
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01-01
- **Primary completion:** 2013-12-31
- **Final completion:** 2020-03-10
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04311580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04311580, "Intravesical Electromotive Mitomycin After Bacillus Calmette-Guérin Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04311580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*